• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估精神分裂症和心境障碍门诊患者的阳性和阴性症状。

Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.

作者信息

Purnine D M, Carey K B, Maisto S A, Carey M P

机构信息

Department of Psychology and Center for Health and Behavior, Syracuse University, New York 13244-2340, USA.

出版信息

J Nerv Ment Dis. 2000 Oct;188(10):653-61. doi: 10.1097/00005053-200010000-00003.

DOI:10.1097/00005053-200010000-00003
PMID:11048814
Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed to assess symptomatology in inpatients with schizophrenia. We examined its reliability and validity among outpatients with schizophrenia (N = 75) and mood disorders (N = 61). Because the hypothesized three-scale structure of the PANSS has not been supported by existing research, we also examined its factor structure. Interrater reliability for individual items and the positive and negative scales was demonstrated. Evidence supported the internal consistency of each scale in the overall sample and the schizophrenia group but was mixed among those with mood disorders. PANSS scores were higher in the schizophrenia group. These scores, in turn, were lower than those generally reported among inpatients with schizophrenia, providing known-groups validity evidence. Four of five factors were similar to those reported among inpatients with schizophrenia. Together, these results support the use of the PANSS among outpatients and reinforce existing support for assessing positive and negative symptoms in mood disorders.

摘要

阳性和阴性症状量表(PANSS)是为评估精神分裂症住院患者的症状学而编制的。我们在精神分裂症门诊患者(N = 75)和心境障碍门诊患者(N = 61)中检验了该量表的信度和效度。由于现有研究并未支持PANSS假设的三分量表结构,我们还检验了其因子结构。研究证明了各条目以及阳性和阴性量表的评分者间信度。证据支持了总体样本和精神分裂症组中各量表的内部一致性,但在心境障碍患者中结果不一。精神分裂症组的PANSS得分更高。反过来,这些得分又低于精神分裂症住院患者中通常报告的得分,从而提供了已知群体效度证据。五个因子中的四个与精神分裂症住院患者中报告的因子相似。总体而言,这些结果支持在门诊患者中使用PANSS,并强化了现有对评估心境障碍中阳性和阴性症状的支持。

相似文献

1
Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.评估精神分裂症和心境障碍门诊患者的阳性和阴性症状。
J Nerv Ment Dis. 2000 Oct;188(10):653-61. doi: 10.1097/00005053-200010000-00003.
2
Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.精神分裂症阳性和阴性症状量表结构化临床访谈的评分者间信度。
Acta Psychiatr Scand. 1994 Mar;89(3):192-5. doi: 10.1111/j.1600-0447.1994.tb08091.x.
3
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.《卡尔加里精神分裂症抑郁量表西班牙语版的跨文化改编与验证》
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
4
Validating specific psychopathology scales in older outpatients with schizophrenia.验证老年精神分裂症门诊患者特定精神病理学量表的有效性。
J Nerv Ment Dis. 1996 Apr;184(4):246-51. doi: 10.1097/00005053-199604000-00008.
5
Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.巴西版精神分裂症卡尔加里抑郁量表的效度研究。
Schizophr Res. 1998 Jun 22;32(1):41-9. doi: 10.1016/s0920-9964(98)00029-2.
6
Assessing positive and negative symptoms in children and adolescents.评估儿童和青少年的阳性及阴性症状。
Am J Psychiatry. 1994 Feb;151(2):249-53. doi: 10.1176/ajp.151.2.249.
7
Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.精神分裂症中阳性和阴性症状量表(PANSS)的心理测量特性。
Psychiatry Res. 1994 Jul;53(1):31-40. doi: 10.1016/0165-1781(94)90093-0.
8
The Greek version of the calgary depression scale for schizophrenia.精神分裂症卡尔加里抑郁量表希腊语版本。
Psychiatry Res. 2000 May 15;94(2):163-71. doi: 10.1016/s0165-1781(00)00137-2.
9
Specificity of the Calgary Depression Scale for schizophrenics.卡尔加里抑郁量表对精神分裂症患者的特异性。
Schizophr Res. 1994 Feb;11(3):239-44. doi: 10.1016/0920-9964(94)90017-5.
10
[A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].基于阳性和阴性症状量表(PANSS)因子结构的慢性精神分裂症四维模型。对153例慢性精神分裂症患者的研究及与简明精神病评定量表(BPRS)因子结构的比较
Encephale. 1997 Jan-Feb;23(1):10-8.

引用本文的文献

1
Symptomatic Profile of Cariprazine in the Context of ICD-11 Domains for Schizophrenia: Review of Clinically Oriented Studies: Симптоматический профиль карипразина в контексте доменов шизофрении в МКБ -11: обзор клинически ориентированных исследований.在国际疾病分类第11版精神分裂症领域背景下卡立普嗪的症状特征:临床导向研究综述:国际疾病分类第11版精神分裂症领域背景下卡立普嗪的症状特征:临床导向研究综述
Consort Psychiatr. 2022 Jan 15;3(1):45-61. doi: 10.17816/CP105. eCollection 2022.
2
Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder.首发未用药的年轻重度抑郁症患者甲状腺功能与脂质代谢异常的关联
Front Psychiatry. 2023 Feb 14;14:1085105. doi: 10.3389/fpsyt.2023.1085105. eCollection 2023.
3
EPA guidance on assessment of negative symptoms in schizophrenia.美国环保署关于精神分裂症阴性症状评估的指南。
Eur Psychiatry. 2021 Feb 18;64(1):e23. doi: 10.1192/j.eurpsy.2021.11.
4
Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial.卢美哌隆治疗精神分裂症的疗效和安全性:一项随机临床试验。
JAMA Psychiatry. 2020 Apr 1;77(4):349-358. doi: 10.1001/jamapsychiatry.2019.4379.
5
The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study.布雷哌唑对成年早期发作精神分裂症门诊患者的疗效:一项探索性研究。
Int Clin Psychopharmacol. 2016 Nov;31(6):307-14. doi: 10.1097/YIC.0000000000000140.
6
An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.针对患有严重精神疾病的社区心理健康患者使用兴奋剂情况的应急管理干预措施的经济评估。
Drug Alcohol Depend. 2015 Aug 1;153:293-9. doi: 10.1016/j.drugalcdep.2015.05.004. Epub 2015 May 14.
7
The influence of treatment attendance on subsequent aggression among severely mentally ill substance abusers.治疗出勤率对严重精神疾病药物滥用者后续攻击行为的影响。
J Subst Abuse Treat. 2014 Nov-Dec;47(5):353-61. doi: 10.1016/j.jsat.2014.06.010. Epub 2014 Jul 13.
8
Service engagement: psychopathology, recovery style and treatments.服务参与:精神病理学、康复方式与治疗
Psychiatry J. 2014;2014:249852. doi: 10.1155/2014/249852. Epub 2014 Feb 12.
9
Validation of the revised Problems Assessment for Substance Using Psychiatric Patients.物质使用障碍患者修订问题评估量表的验证。
Addict Behav. 2011 May;36(5):494-501. doi: 10.1016/j.addbeh.2011.01.024. Epub 2011 Jan 20.
10
Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.外周催产素与精神分裂症症状严重程度降低有关。
Schizophr Res. 2010 Dec;124(1-3):13-21. doi: 10.1016/j.schres.2010.09.014. Epub 2010 Oct 13.